Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis - Trial NCT05560841
Access comprehensive clinical trial information for NCT05560841 through Pure Global AI's free database. This phase not specified trial is sponsored by Karo Pharma AB and is currently Recruiting. The study focuses on Onychomycosis. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Karo Pharma AB
Timeline & Enrollment
N/A
Aug 01, 2022
May 30, 2023
Primary Outcome
To evaluate the effectiveness of Nailner Brush 2-in-1 in the treatment of onychomycosis based on the blinded evaluation of the percentage of healthy nail surface after 6 months of treatment compared to baseline
Summary
Evaluate the effectiveness of Nailner Brush 2-in-1 in the treatment of onychomycosis based on
 the blinded evaluation of the percentage of healthy nail surface after 6 months of treatment
 compared to baseline.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05560841
Device Trial